4
Changes in Ownership
Immuneering Corp Filed Acc 0001104659-21-099733
Chief Scientific Officer bought 1,353 shares at $15.00 ($20,295)
- Chief Scientific Officer acquired 5,040 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Hall Brett Matthew · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-03 | Conversion : show line 1 in the form | +5,040 | 5,040 | D | ||
| 2021-08-03 | Purchase : show line 2 in the form | +1,353 | $15.00 | $20,295 | 6,393 | D |
| Open-market purchases · 1,353 sh · avg $15.00 · $20,295 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2021-08-03 | Conversion : show line 3 in the form Series A Preferred Stock | −1,636 | 1,636 | 0 | D |
| 2021-08-03 | Conversion : show line 4 in the form Series B Preferred Stock | −3,404 | 3,404 | 0 | D |
Loading xslF345X03/tm2123807-6_4seq1.xml…